The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies.
The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies.
复制标题
细菌耐药机制和潜在的抑菌策略
DOI:
10.3390/antibiotics11091215
复制
发表时间:
2022-09-08
影响因子:
4.8
通讯作者:
Cheng, Wei
中科院分区:
文献类型:
--
作者:
Zhang, Fusheng;Cheng, Wei
Bacterial drug resistance is rapidly developing as one of the greatest threats to human health. Bacteria will adopt corresponding strategies to crack the inhibitory effect of antibiotics according to the antibacterial mechanism of antibiotics, involving the mutation of drug target, secreting hydrolase, and discharging antibiotics out of cells through an efflux pump, etc. In recent years, bacteria are found to constantly evolve new resistance mechanisms to antibiotics, including target protective protein, changes in cell morphology, and so on, endowing them with multiple defense systems against antibiotics, leading to the emergence of multi-drug resistant (MDR) bacteria and the unavailability of drugs in clinics. Correspondingly, researchers attempt to uncover the mystery of bacterial resistance to develop more convenient and effective antibacterial strategies. Although traditional antibiotics still play a significant role in the treatment of diseases caused by sensitive pathogenic bacteria, they gradually lose efficacy in the MDR bacteria. Therefore, highly effective antibacterial compounds, such as phage therapy and CRISPER-Cas precision therapy, are gaining an increasing amount of attention, and are considered to be the treatments with the moist potential with regard to resistance against MDR in the future. In this review, nine identified drug resistance mechanisms are summarized, which enhance the retention rate of bacteria under the action of antibiotics and promote the distribution of drug-resistant bacteria (DRB) in the population. Afterwards, three kinds of potential antibacterial methods are introduced, in which new antibacterial compounds exhibit broad application prospects with different action mechanisms, the phage therapy has been successfully applied to infectious diseases caused by super bacteria, and the CRISPER-Cas precision therapy as a new technology can edit drug-resistant genes in pathogenic bacteria at the gene level, with high accuracy and flexibility. These antibacterial methods will provide more options for clinical treatment, and will greatly alleviate the current drug-resistant crisis.
登录
查看更多内容
DOI:
10.1038/s41396-020-00832-7
发表时间:
2021-04
期刊:
The ISME journal
影响因子:
--
作者:
Bottery MJ;Pitchford JW;Friman VP
通讯作者:
Friman VP
DOI:
10.3390/antibiotics10020124
发表时间:
2021-01-28
期刊:
Antibiotics (Basel, Switzerland)
影响因子:
--
作者:
Abdelrahman F;Easwaran M;Daramola OI;Ragab S;Lynch S;Oduselu TJ;Khan FM;Ayobami A;Adnan F;Torrents E;Sanmukh S;El-Shibiny A
通讯作者:
El-Shibiny A
影响因子:
4.1
作者:
Bedi, Manmeet Sakshi;Verma, Vivek;Chhibber, Sanjay
通讯作者:
Chhibber, Sanjay
影响因子:
3.2
作者:
ARIZA, RR;COHEN, SP;DEMPLE, B
通讯作者:
DEMPLE, B
影响因子:
6.4
作者:
Briers Y;Walmagh M;Van Puyenbroeck V;Cornelissen A;Cenens W;Aertsen A;Oliveira H;Azeredo J;Verween G;Pirnay JP;Miller S;Volckaert G;Lavigne R
通讯作者:
Lavigne R